NCT01558921 · BASELINE

Baseline characteristics

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial · Source last updated 2026-05-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants

groups

description
experimental group (arm B) M1 scheme M1 scheme: short course 5 x 5 Gy radiation scheme is followed by six cycles of combination chemotherapy (capecitabine and oxaliplatin (CAPOX)) and surgery. FOLFOX4 may be given as alternative for CAPOX
id
BG000
title
B: 5x5Gy -> CAPOX -> Surgery
description
control group (arm A) standard long course chemoradiotherapy standard long course chemoradiotherapy: long course chemoradiotherapy followed by surgery. Optional adjuvant chemotherapy (CAPOX or FOLFOX) is allowed in the control group.
id
BG001
title
A: 5 Weeks Chemoradiation -> Surgery
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
lower Limit
31
upper Limit
83
value
62
group Id
BG001
lower Limit
23
upper Limit
84
value
62
group Id
BG002
lower Limit
23
upper Limit
84
value
62
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
dispersion Type
FULL_RANGE
param Type
MEAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
162
group Id
BG001
value
138
group Id
BG002
value
300
title
Female
measurements
group Id
BG000
value
300
group Id
BG001
value
312
group Id
BG002
value
612
title
Male
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG002
value
0
denoms
counts
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
units
Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
Race and Ethnicity were not collected from any participant.
title
Race and Ethnicity Not Collected
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
180
group Id
BG001
value
180
group Id
BG002
value
360
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Netherlands
categories
measurements
group Id
BG000
value
168
group Id
BG001
value
160
group Id
BG002
value
328
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Sweden
categories
measurements
group Id
BG000
value
10
group Id
BG001
value
10
group Id
BG002
value
20
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
United States
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
11
group Id
BG002
value
23
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Norway
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
12
group Id
BG002
value
28
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Denmark
categories
measurements
group Id
BG000
value
18
group Id
BG001
value
17
group Id
BG002
value
35
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Slovenia
categories
measurements
group Id
BG000
value
58
group Id
BG001
value
60
group Id
BG002
value
118
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Spain
param Type
NUMBER
title
Region of Enrollment
unit Of Measure
participants

population Description

Eligible patients included in the overall study 468/920 were assigned to treatment B. 462/468 were eligible, 6/468 were ineligible 452/920 were assigned to treatment A. 450/452 were eligible, 9/452 were ineligible

Complete source fields

denoms

counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants

groups

description
experimental group (arm B) M1 scheme M1 scheme: short course 5 x 5 Gy radiation scheme is followed by six cycles of combination chemotherapy (capecitabine and oxaliplatin (CAPOX)) and surgery. FOLFOX4 may be given as alternative for CAPOX
id
BG000
title
B: 5x5Gy -> CAPOX -> Surgery
description
control group (arm A) standard long course chemoradiotherapy standard long course chemoradiotherapy: long course chemoradiotherapy followed by surgery. Optional adjuvant chemotherapy (CAPOX or FOLFOX) is allowed in the control group.
id
BG001
title
A: 5 Weeks Chemoradiation -> Surgery
description
Total of all reporting groups
id
BG002
title
Total

measures

classes
categories
measurements
group Id
BG000
lower Limit
31
upper Limit
83
value
62
group Id
BG001
lower Limit
23
upper Limit
84
value
62
group Id
BG002
lower Limit
23
upper Limit
84
value
62
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
dispersion Type
FULL_RANGE
param Type
MEAN
title
Age, Continuous
unit Of Measure
years
classes
categories
measurements
group Id
BG000
value
162
group Id
BG001
value
138
group Id
BG002
value
300
title
Female
measurements
group Id
BG000
value
300
group Id
BG001
value
312
group Id
BG002
value
612
title
Male
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
param Type
COUNT_OF_PARTICIPANTS
title
Sex: Female, Male
unit Of Measure
Participants
classes
categories
measurements
group Id
BG002
value
0
denoms
counts
group Id
BG000
value
0
group Id
BG001
value
0
group Id
BG002
value
0
units
Participants
param Type
COUNT_OF_PARTICIPANTS
population Description
Race and Ethnicity were not collected from any participant.
title
Race and Ethnicity Not Collected
unit Of Measure
Participants
classes
categories
measurements
group Id
BG000
value
180
group Id
BG001
value
180
group Id
BG002
value
360
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Netherlands
categories
measurements
group Id
BG000
value
168
group Id
BG001
value
160
group Id
BG002
value
328
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Sweden
categories
measurements
group Id
BG000
value
10
group Id
BG001
value
10
group Id
BG002
value
20
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
United States
categories
measurements
group Id
BG000
value
12
group Id
BG001
value
11
group Id
BG002
value
23
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Norway
categories
measurements
group Id
BG000
value
16
group Id
BG001
value
12
group Id
BG002
value
28
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Denmark
categories
measurements
group Id
BG000
value
18
group Id
BG001
value
17
group Id
BG002
value
35
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Slovenia
categories
measurements
group Id
BG000
value
58
group Id
BG001
value
60
group Id
BG002
value
118
denoms
counts
group Id
BG000
value
462
group Id
BG001
value
450
group Id
BG002
value
912
units
Participants
title
Spain
param Type
NUMBER
title
Region of Enrollment
unit Of Measure
participants

population Description

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice